Aller au contenu
Skip to content
Single Peptide Dosages

Ventfort (Vascular Bioregulator) Dosage Protocol

A natural peptide complex extracted from animal vascular tissue, sold as an oral "Cytomax" bioregulator. The studied vascular science belongs to the synthetic tripeptide analog Vesugen (Lys-Glu-Asp) — not to this specific extract, whose composition is proprietary. Russian-registered as a parapharmaceutical; not a drug and not FDA-approved.

Single Peptide Dosages Updated July 18, 2026 11 min read Research information only
Ventfort (Vascular Bioregulator) Dosage Protocol
What it is

A natural peptide complex extracted from animal vascular tissue ("Cytomax" A-3), sold as oral capsules in the Russian peptide-bioregulator tradition. It is a proprietary extract, distinct from its studied synthetic analog Vesugen, the tripeptide Lys-Glu-Asp.

Dosing

An oral capsule, commonly 20 mg, taken as a course: typically 1-2 capsules daily for 10-30 days, repeated 2-3 times per year. No reconstitution, no injection. This is the conventional bioregulator schedule, not a validated therapeutic dose.

Evidence

The vascular data belong to the synthetic tripeptide Vesugen (Lys-Glu-Asp): small Russian clinical work in vasculogenic erectile dysfunction and animal studies of microvascular/endocrine repair. Ventfort itself is a proprietary oral extract with Russian-language, largely uncontrolled human data. Not a drug, not FDA-approved, and unconfirmed by Western trials.

01 · At a glance

Quickstart Highlights

Ventfort (product code A-3) is a natural peptide complex extracted from the vascular (blood-vessel) tissue of young animals, sold in oral capsules as the vascular member of the Russian “Cytomax” peptide bioregulators[1][3]. It is marketed for cardiovascular and circulatory “support.”

The honest framing is the family’s: the studied vascular science belongs to Ventfort’s defined analog — the synthetic tripeptide Vesugen (Lys-Glu-Asp), which has small Russian clinical and animal data on vessels[2][4] — not to this specific extract. Ventfort itself is a natural extract of proprietary composition with Russian-language, largely uncontrolled human data, and it is not a drug and not FDA-approved. This is an educational reference, not medical advice, and it is no substitute for cardiovascular care.

Quick answerVentfort is an oral capsule (commonly 20 mg), taken as a course — typically 1–2 capsules daily for 10–30 days, repeated a few times a year[3]. There is no injection and no reconstitution. Its proposed vascular effects rest on small studies of the analog Vesugen (Lys-Glu-Asp)[2][4], not on controlled trials of this extract; the extract’s own evidence is Russian-only and uncontrolled. Not FDA-approved; sold as a parapharmaceutical.

Supplies Needed

Ventfort is an oral capsule, so there is no reconstitution kit and no injection equipment. What matters is a genuine, well-stored product from a trusted source; as a natural vascular-tissue extract, identity and storage matter more than for a defined synthetic peptide.

Ventfort Capsules
Ventfort Capsules

View Supplier

Protocol Overview

Ventfort is the vascular member of the Cytomax family of natural peptide extracts, sold as an oral bioregulator for cardiovascular “support” in the Khavinson tradition[1][3]. Its rationale is the peptide theory of ageing: short, tissue-specific peptides are proposed to help normalise function in the tissue they derive from — here, blood vessels.

The overview’s honest core is the gap between the family’s science and this product. The vascular data belong to the synthetic tripeptide Vesugen (Lys-Glu-Asp): a small Russian clinical study reported improved penile arterial blood flow in vasculogenic erectile dysfunction, and animal work with the related Lys-Glu-Asp peptide describes microvascular and endocrine repair in aged tissue[2][4]. Ventfort is the natural oral extract, of proprietary composition, with Russian-language and largely uncontrolled human data — a parapharmaceutical, not an approved drug.

Dosing Protocol

Because Ventfort is an oral capsule, the “protocol” below is a course schedule, not a reconstitution ladder. These figures are the conventional bioregulator regimen, not a clinically validated dose for this extract.

Parameter Typical Notes
Capsule 20 mg vascular peptide complex Oral; no reconstitution
Course 1–2 caps daily × 10–30 days Often before a meal
Repeat 2–3 courses per year Conventional “pulse” pattern
What is studied[2] Analog Vesugen (Lys-Glu-Asp) Not the extract itself

Ask what generic AI won't
ChatGPT dodges your Ventfort dosing questions. OpenPeptide answers them.
Documented protocols, real sources, and straight answers — no lectures, no dead ends.

Why researchers study it

Why Ventfort draws research interest

These are the directions researchers and the peptide community most often explore Ventfort for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Circulation & blood flow

The main draw: a vascular bioregulator taken for circulation. The concrete vascular data belong to the synthetic tripeptide Vesugen.

Vascular & endothelial health

Vesugen was studied in a small Russian trial reporting improved penile blood flow — small, and about the analog rather than this extract.

A tissue extract, not a molecule

Purified from animal vascular tissue, so its contents are defined by the manufacturing process rather than a formula.

Not a substitute for treatment

Atherosclerosis and hypertension have proven treatments; the evidence here is Russian-only and uncontrolled.

Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.

Format

An oral capsule, commonly 20 mg of vascular peptide complex. No vial, no reconstitution, no needle.

Course dosing

Typically 1–2 capsules daily for a 10–30 day course, repeated 2–3 times per year[3]. A conventional bioregulator schedule, not an FDA-cleared regimen.

What is actually studied

The synthetic tripeptide Vesugen (Lys-Glu-Asp) has the (small, Russian) vascular data[2][4]; Ventfort is the natural extract, not that studied peptide.

Evidence tier

Bioregulator — Russian-only, largely uncontrolled. Analog data are limited and Russian; the extract’s own claims are unconfirmed by Western trials. Not FDA-approved.

02 · Oral dosing

Oral Dosing Guide

Ventfort is dosed like a supplement course: oral capsules daily for a set number of days, then a break, repeated a few times a year[3]. What follows is that convention, framed honestly against the fact that the concrete vascular data are for the analog Vesugen, not this extract[2][4].

Standard / Gradual Approach

The conventional bioregulator regimen is 1–2 capsules (commonly 20 mg each) once daily for a 10–30 day course, usually before a meal, with courses repeated 2–3 times per year[3]. This short-course, long-gap “pulse” pattern is shared across the Cytomax line and is a convention, not a dose optimised for Ventfort in a controlled trial.

The concrete vascular studies used the synthetic tripeptide Vesugen in specific settings — for example a small monotherapy study in men with vasculogenic erectile dysfunction, and animal models of microvascular and endocrine repair with the related Lys-Glu-Asp peptide[2][4]. Those doses and routes do not transfer to an oral Cytomax capsule of a different (natural-extract) product.

Because there is no validated dose-response for the extract, more is not better and stacking organ bioregulators has no controlled support. The capsule amount is a manufacturing convention; anyone following it is copying a bioregulator schedule for a proprietary natural extract whose own effects have not been shown in controlled Western trials.

03 · What you’ll need

Storage Instructions

Keep Ventfort capsules in a cool, dry place, sealed and out of light, per the supplier’s guidance. As a natural peptide extract it is more sensitive to poor storage than a simple synthetic compound.

Because it is an animal-tissue extract, source and handling matter: a genuine, properly stored product is very different from an unverified grey-market copy with no guarantee of identity or purity.

04 · Good to know

Important Notes

These are the points most often lost when Ventfort is marketed internationally as a “vascular peptide.”

  • The vascular data belong to the analog: the concrete evidence is for the synthetic tripeptide Vesugen (Lys-Glu-Asp), not Ventfort[2][4]. Treating the analog’s small studies as the extract’s own evidence is the core error to avoid.
  • It is a natural extract, not a defined molecule: the capsule contains a proprietary vascular peptide complex, so composition is set by manufacturing and grey-market copies have no guarantee of identity[3].
  • The human evidence is Russian-only and mostly uncontrolled: supportive studies are overwhelmingly Russian-language and frequently unmasked[2]; independent Western controlled trials of Ventfort do not exist.
  • It is a parapharmaceutical, not a drug: Ventfort is not FDA-approved and is sold as a supplement. It must not replace cardiovascular care.
  • Animal-derived: being purified from animal vascular tissue, it carries the general considerations of tissue-sourced biologicals; quality and sourcing matter accordingly.
05 · How it works

How This Works

The proposed mechanism is the peptide theory of ageing applied to the vasculature: short, tissue-specific peptides are proposed to support endothelial and vascular function and counter age-related vascular decline[1].

The concrete data come from the synthetic tripeptide Vesugen (Lys-Glu-Asp). In a small Russian clinical study, Vesugen monotherapy was associated with improved arterial blood flow in men with vasculogenic erectile dysfunction as a manifestation of atherosclerosis[2]; and animal work with the related Lys-Glu-Asp tripeptide describes activation of reparative regeneration and normalisation of microvascular and endocrine tissue in accelerated-aging models[4]. The proposed target is the endothelium and vascular repair.

The honest limit is that this is small analog data, mostly Russian and animal, and it does not establish that the oral natural extract Ventfort produces the same effects. The mechanism is a plausible, long-standing hypothesis with limited supporting studies for the analog — not controlled human proof for this capsule[3].

06 · Daily habits

Lifestyle Factors

For vascular and cardiovascular health, the interventions with overwhelming evidence are behavioural and medical: not smoking, blood-pressure and cholesterol control, exercise, a heart-healthy diet, and treating diabetes. These do vastly more for blood vessels than any oral peptide extract.

The honest “daily habits” note is a redirection: proven cardiovascular basics carry evidence that a Russian-tradition bioregulator does not, and they avoid the risk of substituting a proprietary extract for real vascular care.

07 · What to expect

Potential Benefits & Side Effects

Evidence tier: bioregulator — small analog data (Vesugen; Russian, mostly uncontrolled), and none for the extract itself in controlled Western trials. The “effects” below are largely Vesugen findings; the “considerations” are the honest counterweight.

Reported Effects

  • Reported vascular effect — small analog study: Vesugen monotherapy was associated with improved penile arterial blood flow in vasculogenic erectile dysfunction in a small Russian study[2].
  • Microvascular repair — animal: the related Lys-Glu-Asp tripeptide activated reparative regeneration and helped normalise microvascular and endocrine tissue in accelerated-aging animal models[4].
  • Endothelial-support concept: the bioregulator theory proposes tissue-specific peptides support endothelial and vascular function[1].
  • What is not established: that the oral natural extract Ventfort reproduces any of this in humans. There are no Western controlled trials, and even the analog data are small and Russian[3].

Common Side Effects

  • Reported tolerability is good — from uncontrolled studies: the bioregulators are described as well tolerated, but open-label Russian data are poor at detecting and attributing adverse effects[2].
  • Natural-extract uncertainty: composition is proprietary and animal-derived, so the true content and purity of any product — especially a grey-market copy — are not guaranteed.
  • Cardiovascular caution: a product aimed at the vasculature must never replace evaluation and treatment of cardiovascular symptoms, which can signal serious, treatable disease.
  • Western safety data are absent: without controlled trials outside Russia, the international side-effect profile of Ventfort is not independently characterised.
08 · Oral administration

Oral Administration

Ventfort is taken by mouth as a capsule — there is no mixing, no needle and no injection technique. The steps below keep an oral bioregulator course simple and consistent; they are educational, not medical instructions.

Before You Dose

  • Confirm the product and course: check that you have a genuine vascular bioregulator and know your course length (commonly 10–30 days) and daily capsule count.
  • Understand what it is: a natural vascular-tissue extract sold as a parapharmaceutical, not an approved cardiovascular drug — frame expectations accordingly.
  • Have water ready: capsules are usually taken 15–20 minutes before a meal with water.

How To Take

  • Swallow whole: take the capsule(s) with water, before a meal, once daily unless a specific product directs otherwise.
  • Keep to the course: take it consistently for the course length, then stop — the convention is a short course, not continuous use.
  • Do not over-stack: avoid combining many organ bioregulators; there is no controlled evidence for combinations.

After Dosing

  • Take the gap: after a course, leave the conventional multi-month interval before repeating.
  • Keep cardiovascular care first: continue prescribed cardiovascular treatment and monitoring; treat any chest pain, breathlessness or new symptom as a medical priority.
  • Store it properly: reseal and keep capsules cool, dry and out of light.
10 · The evidence

References

  1. 1
    Neuroendocrinology Letters (2002) — Peptides and Ageing
    Khavinson (PMID 12374906). Foundational review of the peptide-bioregulator theory and the design of short tissue-specific peptides, including vascular-directed peptides; establishes the concept that organ-specific peptides are proposed to normalise function in their source tissue.

    View Source

  2. 2
    Advances in Gerontology (2014) — Efficacy of peptide bioregulators of vessels in chronic lower-limb arterial insufficiency in the elderly
    Kitachev et al., incl. Khavinson (PMID 25051774). A small Russian clinical study of the vasoactive tripeptide Vesugen (Lys-Glu-Asp) in 41 men with vasculogenic erectile dysfunction from atherosclerosis reported improved penile arterial blood flow — the concrete vascular data belong to the synthetic analog, not the extract.

    View Source

  3. 3
    Advances in Gerontology (2008) — Peptidergic regulation of pancreas function in accelerated-aging rats
    Ryzhak, Kvetnoi & Emanuel (PMID 18942368). In irradiation-induced accelerated aging, the tripeptide T-38 (Lys-Glu-Asp) activated reparative regeneration and helped restore disordered microvascular and endocrine tissue — animal support for the Lys-Glu-Asp peptide, not the Ventfort extract.

    View Source

  4. 4
    Advances in Gerontology (2013) — Peptide bioregulators: a new class of geroprotectors (clinical studies results)
    Khavinson, Kuznik & Ryzhak (PMID 24003726). Review of the developing group’s long-term clinical experience with peptide bioregulators — illustrating that the human evidence base is Russian-language and largely from the originating institute.

    View Source

Read the complete guide Peptide Dosage Chart
Step by step

How to take Ventfort

  1. 1Confirm the capsule strength and your target dose from the schedule on this page (each capsule is a fixed strength).
  2. 2Take the required number of Ventfort capsules by mouth once daily, swallowed whole with water, with or without food.
  3. 3Keep the daily dose consistent and follow any documented gradual 4-week escalation steps.
  4. 4Store the capsules sealed at room temperature, dry and away from light — no mixing or refrigeration needed.
FAQ

Ventfort — frequently asked questions

How is Ventfort taken?

Ventfort is taken by mouth as one or more capsules once daily, swallowed whole with or without food. There is no mixing, reconstitution, or injection — it is an oral small-molecule compound, not an injectable peptide.

Do I need bacteriostatic water or syringes for Ventfort?

No. Because Ventfort is an oral capsule, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — you simply take the capsule(s) by mouth.

How many capsules make up each dose?

Each capsule is a fixed strength, so a target dose is reached by taking the matching number of capsules at that strength. The dosing table on this page lists the reference dose for each step of a documented research schedule — match your capsule strength to it rather than assuming a fixed number.

How should I store Ventfort?

Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product. No refrigeration or reconstitution is required.

How does Ventfort differ from injectable peptide protocols?

The main practical difference is the route of administration: Ventfort is swallowed as a capsule, so there is no reconstitution, bacteriostatic water, or sterile injection technique involved. Its specific mechanism of action and the research behind it are described in the "How This Works" section on this page.

Is the research-grade Ventfort sold here approved for human use?

No. Research-grade Ventfort is supplied strictly for laboratory and research purposes and is not an approved medicine for human use — regardless of whether an approved pharmaceutical product containing this ingredient exists. Everything here is research information, not medical advice; consult a licensed healthcare professional and the approved product labeling before any use.

Stay precise

New protocols & dosing updates

Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.